3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Phase 3
1
Phase 2
1
Phase 1/2
1
Status
Enrolling by invitation
1
Sponsor Class
INDUSTRY
158
OTHER
48
NIH
7
OTHER_GOV
2
UNKNOWN
1
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Carcinoma, Non-Small-Cell Lung
1
Interventions
Paclitaxel
6
Radiotherapy
3
Epirubicin
3
Radiotherapy, Intensity-Modulated
2
Radiation Dose Hypofractionation
2
Radiation
2
Docetaxel
2
Cyclophosphamide
2
Cisplatin
2
Carboplatin
2
Capecitabine
2
pegylated granulocyte colony-stimulating factor
1
nabiximols
1
aumolertinib
1
Zoledronic Acid
1
Vinorelbine
1
Temozolomide
1
TP protocol
1
Standard of Care
1
S 1 (combination)
1
Platinum
1
Pemetrexed
1
Neoadjuvant Therapy
1
Irinotecan
1
Granulocyte Colony-Stimulating Factor
1
Drug Therapy
1
Decitabine
1
Chemotherapy, Adjuvant
1
Cetuximab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
UNKNOWN
×
Pemetrexed
×
Clear all
NCT04762459
2022-02-24
APEX
ChineseAMS
Phase 3
Enrolling by invitation
606 enrolled